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The COVID-19 pandemic is presenting significant challenges for health and social
care systems globally. The implementation of unprecedented public health measures,
alongside the augmentation of the treatment capacity for those severely affected by
COVID-19, are compromising and limiting the delivery of essential care to people with
severe substance use problems and, in some cases, widening extreme social inequities
such as poverty and homelessness. This global pandemic is severely challenging
current working practices. However, these challenges can provide a unique opportunity
for a flexible and innovative learning approach, bringing certain interventions into the
spotlight. Harm reduction responses are well-established evidenced approaches in the
management of opioid dependence but not so well-known or implemented in relation
to alcohol use disorders. In this position paper, we explore the potential for expanding
harm reduction approaches during the COVID-19 crisis and beyond as part of substance
use treatment services. We will examine alcohol use and related vulnerabilities during
COVID-19, the impact of COVID-19 on substance use services, and the potential
philosophical shift in orientation to harm reduction and outline a range of alcohol
harm reduction approaches. We discuss relevant aspects of the Structured Preparation
for Alcohol Detoxification (SPADe) treatment model, and Managed Alcohol Programs
(MAPs), as part of a continuum of harm reduction and abstinence orientated treatment
for alcohol use disorders. In conclusion, while COVID-19 has dramatically reduced and
limited services, the pandemic has propelled the importance of alcohol harm reduction
and created new opportunities for implementation of harm reduction philosophy and
approaches, including programs that incorporate the provision of alcohol as medicine as
part of the substance use treatment continuum.
Keywords: harm reduction, structured preparation for alcohol detoxification, managed alcohol programs, alcohol,
COVID-19
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INTRODUCTION
On March 11, 2020 the World Health Organization declared
a global pandemic due to the novel coronavirus (1). The call
rippled globally resulting in the implementation of public health
measures including travel restrictions, stay-at-home orders,
frequent handwashing, physical distancing, and self-isolation (2).
COVID-19 has dramatic implications for those with alcohol use
disorders (AUD) due to changes in the severity and pattern
of drinking, changes in access to services with restrictions and
closures, as well as significant shifts in the mode of delivery of
substance use services (3, 4). The pandemic demands attention
to the continuum of substance use services, including alcohol
harm reduction, and the specific needs of those impacted
by intersecting crises of alcohol use disorders, poverty and
homelessness (5, 6).
Harm reduction to prevent the transmission of blood borne
diseases, prevent overdoses, and provide an alternative to an
unsafe illicit drug supply, is underpinned by the goal of reducing
harm associated with illicit drug use (7, 8). Alcohol harm
reduction, like other harm reduction approaches, aims to reduce
the harms of alcohol without necessarily requiring a reduction
in, or stopping, drinking (9). Strategies to reduce harm from
alcohol often focus on general population strategies, such as low
risk drinking guidelines and population-based policies related
to pricing and other forms of regulation, to reduce overall
population harm. While critically important to population
health, this approach is not sufficient to reduce individual
harms for some groups, and may even have unintended
consequences that increase harms (8). While there is robust
evidence for interventions to reduce harms of illicit drug use,
much less attention has been paid to reducing the many
harms associated with alcohol use, specifically heavy episodic
drinking, chronic use, and illicit and non-beverage alcohol
use. Alcohol harm reduction for individuals this includes
pharmaceutical alternatives to reduce cravings, potential use
of cannabis as a substitution for alcohol, social interventions
such as Housing First programs where substance use including
alcohol use is tolerated, safer drinking education, and programs
that provide alcohol. During the COVID-19 pandemic, the
importance of alcohol harm reduction as an adjunct to other
approaches has become increasingly prominent due to changes
in service provision.
In this position paper, our objectives are to: (i) explore
the shifts in relation to harms associated with AUD during
COVID-19; (ii) illustrate both adverse and optimal changes
in substance use and addiction services during the pandemic,
and; (iii) underscore the philosophical shifts and opportunities
for enhancing harm reduction strategies for those with AUD
during the pandemic and beyond. We draw on international
literature, wherever available, with specific examples from the
UK and Canada. We did not undertake a systematic search of
the literature but team members collated specific COVID-19 and
AUD publications throughout the pandemic, most specifically
utilizing the Society for the Study of Addiction COVID-19
research/briefings/evidence web-based resource (10). Our aim is
to highlight harm reduction as an important approach and set
of strategies for reducing alcohol related harms as part of health
care systems and alongside treatment services during COVID 19
and beyond.
ALCOHOL RELATED HARMS AND
VULNERABILITY
In 2016, the use of alcohol was estimated to result in 2.8
million deaths (5.3% of all deaths) worldwide and 132.6 million
disability-adjusted life years (DALYs) (11). Alcohol related
mortality exceeds that caused by other communicable and
non-communicable diseases, such as tuberculosis, HIV/AIDS
and diabetes. Harms from alcohol and other drugs can be
classified into those which are: (i) “acute,” comprising injuries,
poisonings and/or acute illnesses partly caused by an episode
of heavy use; (ii) “chronic,” comprising a range of chronic and
relapsing conditions including liver disease, cancers, strokes
and gastrointestinal diseases which are caused by the overall
volume of alcohol consumed over time (12), and; (iii) “social,”
which may involve problems in the spheres of housing, finances,
relationships, the law, and workplace (12). Contextually, harms
are increased along the socio-economic gradient, with increased
alcohol-related harms experienced by those with low socio-
economic status (13–16).
AUDs are experienced by 3–4% of the population globally
(17). DSM-V includes dependence under the category of AUD
and is defined as a clustering of signs of increased tolerance, the
experience of withdrawal, continued use despite the experience
of problems, and a degree of impaired control over consumption
(18). Alcohol dependence carries heavy health and social costs
which are increased when associated with poverty, homelessness,
and/or housing instability (19–21). An international review
found 10 studies concerning severe AUD experienced by men
who are homeless but little data was available for homeless
women (22). Among homeless men in economically developed
countries, the prevalence of severe AUDs has been estimated to
be almost 40% (22). Homelessness is associated with higher rates
of depression, suicide, chronic pain, and poor mental health,
alongside inadequate housing, food and other insecurities, as
a consequence of severe poverty (23–26). The combination of
severe AUDs and homelessness is often a response to, and
a consequence of, multiple intersecting structural, systemic,
and individual factors, in which alcohol can be a means of
coping (27–29).
The relationship between stress and alcohol use is bilateral.
Stress has been recognized as a predisposing risk factor for the
development of AUD, and chronic alcohol use can exaggerate the
experience of stress and compromise the ability of the individual
to cope with stress (30). In the early stages of the pandemic,
two opposite scenarios were introduced based on a review of
the impact of previous epidemics by Rehm et al. (31). The first
scenario predicted an increase of consumption, in particular in
men, due to increased stress, and the second scenario predicted a
reduction of consumption due to a reduction of access to alcohol,
due to the social distancing measures (31). In fact, policymakers
in many countries deemed alcohol sale to be “essential” and
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loosened alcohol restrictions e.g., allowing internet orders and
home delivery. It seems that two main factors [vulnerability to
stress and increased access to alcohol), had a synergic impact
that further exaggerated pre-exisiting vulnerabilities of people
with AUD (4). There is emerging evidence that alcohol use
increased during the early phase of the pandemic, in both the
general population (32, 33) and the population with pre-exisiting
AUD (34)]. It has been also documented that limited access to
alcohol led to increased frequency of abrupt discontinuation, and
a temporary uptick in presentations to hospital for management
of alcohol withdrawal symptoms experienced by dependent and
heavy drinkers (4). This change in consumption, in conjunction
with limited access to generic health and specialist services, plus
the impact of the pandemic on social care and social stability,
suggest the need to review the potential usefulness of alcohol
harm reduction strategies during the COVID-19 period.
CHANGES TO SERVICE PROVISION
DURING COVID 19 FOR PEOPLE WITH
AUD
COVID-19 has affected every healthcare system in the world,
even in countries that have not had high numbers of COVID-
19 case numbers. According to Sutherland et al. [(35), p8],
“different healthcare systems have seen varying patterns of changes
in healthcare activity – depending on prevalence, the stage of
the pandemic and local policy.” Preparations to help health and
social care services cope with anticipated increased demand from
patients with severe cases of COVID-19, and the requirement
to reduce the risk of infection/transmission, led to tremendous
global changes in health service provision for non-COVID-
19 related conditions, and also to public expectations of what
would be provided by healthcare services (4). For example,
Sutherland et al. (35) investigated changes in New South
Wales, Australia using healthcare data drawn from multiple
sources. Their study found that, between March and June 2020,
compared with the same period in 2019, primary care face-to-
face consultations decreased by 22.1%, breast screening activity
by 51.5%, ambulance incidents by 7.2%, emergency department
visits by 13.9%, public hospital inpatient episodes by 14.3%,
and public hospital planned surgical activity by 32.6%. They
concluded that there were substantial declines in a wide range
of healthcare activities across the NSW health system over this
period and, while activity was recovering by September 2020,
they had still not returned to “normal.” There was widespread
deferment of scheduled appointments and procedures to attempt
to accommodate the actual or predicted COVID-19 cases.
Across the world, staff were redeployed to unfamiliar
environments away from services deemed non-essential to the
COVID-19 response (36). This also involved the need for
retraining and repurposing of staff resources. In England, for
example, new staff such as trainees in the early stages of
their career (foundation and core trainees), retired colleagues,
or staff from other hospital departments, were deployed to
increase capacity within emergency departments. These staff
might not have been aware of existing protocols for cross
departmental coordination, coordination with primary care, or
secondary care specialist services such as drug and alcohol
services. Restrictions of provision of substance use hospital
liaison services was also experienced. This was due in part to
generic measures employed to protect staff (rotation of work
force or over the phone advice), as well as re-deployment of acute
hospital staff, such as phlebotomists, clinical and administrative
staff. This led to major reductions in/lack of access to services
such as provision of liver function tests and regular hepatology
outpatient appointments (37). Another important factor during
the initial period of the COVID-19 response was fear on behalf
of the public regarding the risk of infection if they approached
health services impacting on seeking help for non-COVID-19
conditions, and a reluctance to place additional burden on health
care services (35). For people with AUD, this could exacerbate
pre-existing fragmentation in service provision and contribute
to the long term deterioration of health and unnecessary
therapeutic pessimism (4). Services were also reconfigured to
accommodate the need for physical distancing, for example
by moving services on to virtual platforms (35). The above
mentioned barriers are increased for people impacted by severe
AUD, poverty and/or homelessness, who may lack access to
primary care.
Changes to Specialist Substance
Use/Addiction Services
As documented during a temporary alcohol prohibition in
India (38), temporary spikes in treatment seeking for alcohol
withdrawal may occur initially but these rapidly decline, as has
also been documented during other major alcohol restrictions
(39). There is a complex interplay over time between alcohol
supply and alcohol harm. During COVID 19, requirements for
social distancing introduced by most countries have led to major
changes to substance use specialist service provision. The most
common changes adopted across a range of countries were (i)
stopping provision of treatment via structured group work, (ii)
stopping community detoxification, and (iii) reduction of face to
face consultation to the minimum and, in some cases, reduced
access to withdrawal management and rehabilitation services
(36, 40). These changes have disproportionally affected substance
use service provision for individuals with AUDs (39, 41). In some
countries, addiction/substance use services were deemed to be
essential services and thus protected from having staff resource
redeployed (36). It is important to note that, while there were
extensive clinical guidelines and advice being issued early in
the pandemic to provide continuity of service and contingency
planning (36), it was hard for service providers to adapt quickly
while also continuing to provide services (6, 42–44). There is also
the risk that the most vulnerable sub group of people with AUD,
such as those experiencing homelessness and unemployment,
would not necessarily have the technology to be able to access
virtual services offered by phone or computer (5, 6). There are
examples of attempts to address those barriers, for example in
Scotland where phones were distributed to this group to address
digital barriers (45). This population also lost other community
supports such as access to food banks, due to reduced capacity
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and requirements for social distancing (6) and for some loss of
income from begging/panning and recycling.
Mental Health Impact and Access to
Mental Health Services
Themental health impact of various elements of the pandemic on
the general population and on people with pre-exisiting mental
health conditions was acknowledged early on by the scientific
community (46–50). Similar impacts were therefore expected for
vulnerable people with substance use problems such as AUD
(36). According to DeJong et al. (36) who conducted a qualitative
study with people in substance use treatment including for
alcohol problems in the Netherlands, COVID-19 feelings of
anger, guilt, gloom, fear, panic, restlessness, and stress were
reported by participants, along with social isolation, lack of
structure and boredom. The additional stress of a pandemic
can create additional vulnerabilities in relation to physical and
psychological health (51), and also increase risk of relapse (52).
Increased levels of stress due to fear of infection, illness and
death, as well as financial stressors, can increase levels of stress
experienced by an already vulnerable population with AUD that
is additionally compromised due to chronicity of drinking (36).
Social Care and Community Services
Prior to COVID-19, individuals with both severe AUD and
homelessness faced significant barriers to accessing temporary
accommodation and, in some cases, had to go without shelter
as a consequence of alcohol use (53). Pre-existing structural
vulnerability and alcohol related harms for this population were
escalated with the announcement of the global pandemic in
March 2020. Individuals may also have had difficulties accessing
beverage alcohol due to restricted hours, restrictions on the use
of cash, and implementation of isolation measures and restrictive
policies that limited guests or public access (6). Additionally,
socioeconomic factors may affect purchasing ability, such as
loss of income from begging, pan handling, and closure of
bottle or recycling depots (41). These factors may shift patterns
of drinking in ways that increase harms, or lead to other
unanticipated consequences, such as alcohol withdrawal, alcohol
poisoning and/or substitution of illicit drugs for alcohol. Due
to costs and availability, use of non-beverage alcohol such as
hand sanitizer and rubbing alcohol can increase among those
who are homeless posing significant harms (54). Also, this group
may experience more serious COVID-19 symptoms due to the
higher risk of pneumonia and compromised immune function
associated with high levels of alcohol consumption (55). Further,
the requirements of physical distancing and self-isolation may
contribute to even greater social isolation, marginalization, and
loss of social networks.
STRATEGIC CHANGE IN TREATMENT
PHILOSOPHY TOWARD HARM
REDUCTION
A harm reduction approach, beyond the provision of safety
from unwanted withdrawals, that can be combined with other
treatment components across a range of settings, such as
emergency departments, primary care and specialist community
services, became necessary during the pandemic. Phone and
digital consultations were widely used during this period to
support clients in opioid substitution treatment, alongside other
measures and modifications compatible with social distancing.
For individuals with AUDs, however, where substitution was
not an option, digital or phone consultations, might not be
sufficient, whilst other components of the treatment pathway,
such as detoxification and group work, are interrupted. To
maximize their effectiveness these consultations should be
planned and structured with the aim of maintaining a therapeutic
component (56).
A harm reduction approach, informed by the changes
required during the COVID-19 pandemic, as applied in harm
reduction for opioid treatment (57), is therefore needed.
Managing risks around COVID-19 could mean self-isolation and
reduction of income which, in turn, might put the ability of the
person to maintain stable levels and patterns of drinking at risk.
This may increase risk of severe withdrawal complications (e.g.,
seizures) (4, 58). Harm reduction advice to maintain stable levels
of drinking, while facilitating engagement with AUD services,
could be expanded in conjunction with AUD services, given
the lack of access to community detoxification, acute hospital
admission, or reduced access to inpatient specialist detoxification
services. However, expansion of alcohol supply has to always
be carefully balanced against the high level of demonstrable
harm to health attributed to alcohol, with rates of associated
morbidity, mortality and economic costs far higher than for other
substances (59).
The harm reduction approach is compatible with an
overall pre-habilitation approach to the management of AUD.
Pre-habilitation advocates the identification and proactive
management of; (i) any factors anticipated to compromise the
successful outcome of an intervention, and; (ii) the potential
side effects associated with the intervention itself. It is a pro-
active rather than a reactive approach aimed at ensuring more
sustainable outcomes (60). Harm reduction, using alcohol as an
agent of treatment, could achieve both aims (54). The concept of
pre-habilitation is not new. The ability to predict, or anticipate,
certain harm, or assess certain risks, is associated with the
human ability of learning from experience, modifying behavioral
responses, and developing long-term and sustainable response
strategies. To that effect, planning in advance, in anticipation of
risks, can be considered to be an essential strategy and quality,
associated with individual survival and progress.
POTENTIAL HARM REDUCTION
STRATEGIES WITHIN A HARM
REDUCTION FRAMEWORK FOR PEOPLE
WITH AUD
Alcohol harm reduction for individual clients refers to a range
of strategies and approaches that specifically seek to reduce the
harms of alcohol without necessarily requiring a reduction in,
or stopping, drinking. Specific alcohol harm reduction strategies
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include: (1) use of pharmaceutical alternatives to reduce cravings;
(2) use of cannabis as a substitution for alcohol; (3) social
interventions such as Housing First programs where substance
use and alcohol use is tolerated; (4) safer drinking education; (5)
substitution programs that provide alcohol. Although individuals
experiencing severe AUD and homelessness often express a
preference for harm reduction goals, there is limited discussion
and availability of specific alcohol harm reduction strategies (61–
63). We will provide a brief overview of the first four strategies
and provide more detail on substitution programs that provide
alcohol, such as SPADE and MAP, as forms of alcohol harm
reduction that could be enhanced in substance use services. We
will comment on the need for the strategy during COVID 19 and
any particular challenges and adaptations that the COVID-19
pandemic might necessitate to those strategies.
Pharmaceutical Alternatives
Pharmaceutical alternatives include use of medication such as
Naltrexone or Acamposate to manage craving and withdrawal
symptoms, and may be used alone or in combination with
other approaches such as motivational interviewing. Different
medications are approved for use in different countries (58).
Limited access to health services due to the pandemic (as
discussed in section Social Care and Community Services
above) might have reduced capacity for baseline and ongoing
monitoring such as liver function tests, necessitating adaptation
of the clinical protocols to pandemic mode.
Cannabis Substitution
Cannabis use has also been suggested as a substitute for alcohol.
Where abstinence is neither feasible or preferable, cannabis
has been used within a harm reduction framework to reduce
use of other substances and help meet goals of reducing harm
(64–66). In particular, cannabis substitution has been proposed
as a potential harm reduction strategy for those with alcohol
dependence (67). Cannabis substitution for alcohol problems
meets, or partially meets, the seven criteria for evaluating the
use of substitution medicines developed by Chick and Nutt (68).
The need for further evidence through clinical trials has been
recommended (68). While cannabis use is not without harm, it
is argued that the scale of harms is substantially lower than for
alcohol (68, 69). It has the potential to stave off cravings and
reduce withdrawal, as well as having a potential beneficial effect
for pain, PTSD, anxiety, and sleep (69). However, cannabis can
potentiate the effects of alcohol and more evidence is needed
as to its use and effectiveness with people with AUD. During
COVID-19, especially in the context of legalization of cannabis,
or in a medical context, such a strategy could be considered
harm reduction where other interventions are not accessible or
unacceptable, and with appropriate guidelines for safe use.
Housing First
Tolerance of substance use in Housing First programs has been
associated with improved costs and better outcomes for those
able to manage their own alcohol use (70–73). This strategy
is even more crucial during the period of the COVID-19
pandemic as housing is a front line defense against COVID-
19. There are indications that the financial and social impact
associated with the measures taken to manage the pandemic
has increased unemployment, loss of income, and in some cases
homelessness (74).
Safer Drinking Education
In some cases, safer drinking education has been incorporated
as an intervention in Housing First programs to reduce harms.
Safer drinking education includes provision of information and
education by peers that focuses on reduces the risks of drinking
(75). This approach could be used in a wide range of community
settings including outreach, shelters and drop-ins. Specifically,
two of the authors led the development of safer drinking tips
during COVID 19.
Substitution Programs That Provide
Beverage Alcohol
The principles of a harm reduction approach that helps people
who use opioids to stay alive and, safe, and which provides easy
access into other components of treatment, has relevance for
people with AUD. While there is no substitution substance for
alcohol, managed access to beverage alcohol has been provided
by Managed Alcohol Programs (MAP)s in Canada, often to
replace use of non-beverage alcohol, which may both be more
intrinsically harmful, and easier to consume in harmful quantities
due to higher alcohol concentrations and lower prices. Structured
Preparation for Alcohol Detoxification (SPADe) and MAP are
now examined in more depth as harm reduction approaches
that provide alcohol as medication within a harm reduction
framework which, during the COVID-19 period, can reduce the
risk and severity of abrupt and unplanned withdrawal, as well as
harms related to use of non-beverage alcohol.
Structured Preparation for Alcohol
Detoxification (SPADe)
The emphasis of SPADe is on stable drinking and avoidance of
major fluctuations in the amount and pattern of drinking as the
first step toward preparation for abstinence, as well as a final
aim for controlled drinking. The SPADe approach, although not
described as “harm reduction” per se, has similar components
to a harm reduction approach, given that it promotes the use
of alcohol as a medication, with frequent and regular dosing
to prevent rather than treat withdrawal symptoms. Within
SPADe, the main aim is the stabilization of both the amount
and pattern of drinking. This type of controlled drinking is
referred to as “partial” for two main reasons: (a) it is an
intermediate treatment stage rather than the final treatment
aim, which remains abstinence and; (b) the amount and pattern
of drinking during this process is not always within healthy
limits (76).
This proactive elimination of symptoms is considered
fundamental from a biological perspective as it protects against
brain acute dysregulation which, in turn, might sensitize the
brain, leading to an exaggeration of the negative impact
associated with the disturbance of the brain’s homeostatic
system. From a psychological perspective, it empowers the
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individual through regaining some control of decision making,
thus reducing the impulsivity associated with the experience or
avoidance of experiencing cravings and withdrawal symptoms.
Furthermore, it provides a relatively stable environment for
the individual and the close social environment to start
implementing lifestyle changes leading to increased self-efficacy
which is considered to be the final mediating factor in social
learning theory and cognitive and behavioral treatment models
(77, 78).
The amount of drinking, following stabilization of the patterns
described above, could be reduced gradually following the
principle of small sustainable changes. The aim is to avoid any
dramatic change to the amount of drinking that might not only
be unsustainable but also lead to precipitation of withdrawal
symptoms which, on rare occasions, might potentially be life
threatening. Once stability is achieved then gradual reduction can
be safely initiated. Roughly half of the individuals would be able
to stop using alcohol without the use of detoxificationmedication
(79). This model of detoxification is called “guided self-detox”
and refers to the process of using alcohol “as if it was medication”
and as a safe detoxification tool. During the period of COVID-
19 pandemic, with the associated limitations in specialist service
provision, the stabilization of drinking and the guided self-detox
wherever possible, rather than detoxification seems to be a safer
and more realistic treatment aim.
Within the SPADe original approach, guided self-detox can be
achieved more easily if other lifestyle changes are taking place at
the same time, and family and important others (if present) are
aware and supportive of the plan. These are the other two crucial
components of SPADe. Early and gradual implementation of
changes within the individual’s lifestyle are necessary to provide:
(i) a routine in everyday life that would protect from early relapse;
(ii) fill in the void that alcohol detoxification would leave behind;
(iii) could be used as distraction strategies against cravings; (iv)
would enhance personal responsibility; (v) would de-mystify
alcohol and challenge the omnipotence of cravings or withdrawal
symptoms, and finally; (vi) would protect from the acute stress
experienced in the early days of abstinence. According to SPADe,
these lifestyle changes should be initiated and tested while
alcohol is stabilized and to be augmented, as well as evaluated,
after the detoxification. The involvement of family members
and the immediate social support system helps by providing
education, modifying unrealistic expectations, and supporting a
more gradual adaptation to the new family dynamics (following
the removal of alcohol). It helps with managing anxiety and
the difficult feelings/emotions associated with broken trust and
promotes a partnership approach. The fundamental reason for
this involvement is that recovery is easier and more sustainable
within a respectful, stress-free, and supportive environment.
These lifestyle changes and possible family involvement should
be discussed in depth with the individual as they might be
particularly challenging due to social restrictions associated
with COVID-19.
Managed Alcohol Programs (MAPs)
MAPs go beyond tolerance of alcohol onsite in housing or other
accommodation. MAPs are a strategy to assist people to manage
their alcohol use with the aim of reducing harms of consumption,
including consumption of non-beverage alcohol (80). In Canada,
we witnessed the growth and implementation ofmany newMAPs
with the onset of COVID 19. The need forMAPs during COVID-
19 was a strategy to assist with physical distancing and self-
isolation by reducing the need for participants to source alcohol
daily, as well as reducing risks of withdrawal and avoiding use of
non-beverage alcohol and substitution of illicit drugs associated
with high rates of overdose deaths. In British Columbia, specific
operational guidance was released to assist with the development
of a range of models (81).
MAPs originated as a response to the complex needs of people
who do not respond to abstinence programs and are experiencing
homelessness or housing instability (82). A maximum number of
doses are provided to participants daily. MAPs intend to replace
non-beverage alcohol, heavy drinking episodes, and intoxication,
with a steady source of alcohol, and thereby reduce acute alcohol-
related harms (82). To the extent that MAPs contribute to
reductions in total alcohol consumption among people with
AUDs who are not willing or able to abstain, they may also
contribute to lower risks of serious alcohol-related diseases,
though these will still be high compared to general population
(83). MAPs offer regulated access to beverage alcohol, alongside
meals, healthcare, accommodation and a range of social supports.
There are a wide range of models, from community programs
led by people with lived experience, to programs in shelters,
transitional and supportive housing, and hospitals. Despite the
range in models, the goals of MAPS are to reduce harms and
provide an option for those who have not been successfully
supported by other approaches and do not wish to stop drinking.
MAPS seek to provide an alternative to street-based survival
drinking and/or use of non-beverage alcohol. An important
element of MAPs, consistent with a harm reduction framework,
is the involvement of people with lived experience in design,
development, and delivery of programs (53, 54, 84, 85).
Podymow and colleagues first documented the impacts of
MAPs in 2006, based on a program in Ottawa, and found
benefits related to reduced hospital and policing costs, improved
hygiene and nutrition, and increased medication compliance
(82). The Canadian Managed Alcohol Study (CMAPS) began in
2011 and is the largest study to date of MAP implementation
and outcomes (www.cmaps.ca). Initial studies of MAPs found
evidence of reduced alcohol-related harms, reduced use of non-
beverage alcohol, improved quality of life and safety, increased
housing stability, and reduced demands and costs for the health
and criminal justice systems (86–88). Management issues related
to eligibility criteria, and tailoring programs to individual needs,
were identified. In a comparison of 175 MAP participants and
189 controls in five cities, Stockwell et al. found that long-term
MAP residents (>2 months) drank significantly fewer drinks per
day than controls over the previous 30 days (83). In this same
analysis, long-term MAP residents reported significantly fewer
acute alcohol-related harms in the domains of health, safety,
social, legal, and withdrawal symptoms. The same participants
reported that, when unable to afford alcohol, they would often
use positive coping strategies e.g., waiting for money (46%), make
supplies last longer (53%), seek treatment (37%) or go without
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alcohol (39%), and be less likely to use strategies with negative or
harmful consequences, such as use illicit drugs (usually cannabis)
(28%) and/or non-beverage alcohol (30%) (75). Compared to
controls, the long-term MAP residents were significantly less
likely to use illicit substances, steal, or go without alcohol, and
they were more likely to seek treatment. In the first longitudinal
analysis of 59 MAP participants and 116 controls, Stockwell
et al. (89), found that MAP participants drank less hazardously
than controls and experienced fewer alcohol related harms at 0–
6 months than controls (89). Additionally, qualitative findings
from MAP participants suggested that being in a MAP disrupts
survival drinking and cycling through multiple settings (which
is particularly important to reduce movement in the context of
COVID-19), as well as enhancing feelings of safety, belonging,
sense of place or home, and hope for the future (90). This
evidence indicates that acute and social harms (e.g., injuries,
poisoning) can be reduced for this population by engagement
in a MAP. In order to reduce chronic harms, and elevated risk
of alcohol-related diseases created by a program of continuous
daily alcohol administration, attention to program policies and
administration is critical (83, 89).
In summary, MAPs have been shown to enhance housing
stability, reduce acute and social alcohol-related harms,
improve safety, and create opportunities for reconnection
with families, communities, and healing. However, there
has been limited research on programs that incorporate sex
and gender considerations, or the needs of ethnically diverse
populations as the majority of the existing programs primarily
serve men. A recent study conducted in Scotland that aimed
to explore the potential of MAPS concluded that the model
held much promise for implementation across Scotland and
potentially in the UK more widely, and recommended that
they should be taken forward into pilot implementation (63).
MAPs fill an important gap for those who require additional
support to manage alcohol use in order to maintain stability
and, during COVID-19, adhere to stay at home and physical
distancing measures.
DISCUSSION
Services for people with AUD have largely focused on treatment
approaches that have a goal of abstinence. Arguments for
the appropriateness of harm reduction strategies for the most
vulnerable subgroup of people with AUD, namely people who
are homeless, is not new (7, 91). Implementation of public health
measures to reduce the spread of COVID-19 have increased
alcohol consumption in some countries (32), especially those
that have relaxed policies on alcohol availability and pricing.
This has added to pressures on service provision for people with
AUD and highlighted the need for new approaches during a
pandemic (92, 93). Reductions in, and substantial limitations of,
provision of services to this group has created an opportunity
for a further shift in philosophy toward harm reduction in
substance use services, as well as implementation of services
that focus on substitution, tolerance, and safer or managed use
of alcohol. Medications that help to manage alcohol craving or
withdrawal are often used when the goals are for abstinence,
while cannabis substitution may provide a less harmful substance
to replace alcohol. In addition, safer drinking education (e.g.,
about lower risk beverages, contexts and drinking patterns) is a
harm reduction strategy that has been incorporated into Housing
First initiatives but could be provided in other community
settings. In this paper, we have discussed the strategic need and
evidence for the enhancement of treatment services through
the explicit incorporation of alcohol harm reduction approaches
both during the COVID-19 period and beyond.
While there is a growing evidence base for alcohol harm
reduction beyond population level policies that seek to reduce
overall harms, we recognize that the incorporation of alcohol
harm reduction approaches described here require philosophical
shifts as well as policy shifts. Our view is that such shifts, and the
associated change of attitudes toward one of the most vulnerable
and marginalized groups in society, would contribute toward the
reduction of discrimination and systemic neglect of their needs.
To be clear, we are not proposing that all services be oriented to
harm reduction but, rather, that harm reduction be a recognized
and accepted approach within mainstream substance use services
in order to expand access to a broader range of services based
on client choice and goals. It is the underlying values base of
harm reduction in which the explicit intention is to reduce harm
that has created controversy as it conflicts with long established
and often dominant norms of abstinence as the ultimate goal
of substance use services for people with AUD. Paradoxically
there are individuals often impacted by structural inequities and
vulnerability who are left out or even potentially impacted by
unintended consequences of such policies (13).
In this position paper, we have specifically examined
approaches that provide alcohol within a harm reduction
framework, namely SPADe and MAPs. While both provide
alcohol, and share goals related to reducing harm through
provision of a safe and regular source of alcohol to address
harms of binging and smoothing out of drinking patterns, there
are differences between the two approaches. The ultimate aim
of SPADe is abstinence, while MAPs aim to reduce harms as a
primary goal with or without necessarily resulting in eventual
abstinence. Both take a pragmatic and incremental approach
to provision of alcohol which is aligned with harm reduction
principles more generally (8). Our view is that there is much
that can be learned from both approaches in meeting the
needs of clients with severe AUD. For example, MAPs might
incorporate elements of SPADe for clients who express an interest
in reducing alcohol consumption and/or goals of abstinence.
Alternatively, SPADe programs may identify clients who would
be better suited toMAPs. As such, the existence of such programs
provides an expanded range of services for those with severe
AUD who are often overlooked or underserved by current
treatment systems.
CONCLUSION
Alcohol harm reduction that spans tolerance of ongoing drinking
and provision of alcohol, as well as substitution, have become
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more important during COVID-19. However, such approaches
have a history preceding COVID-19 and a place in the broader
landscape of harm reduction that is often dominated by
illicit drugs. While COVID-19 has dramatically reduced and
limited services, the pandemic has propelled the importance
of alcohol harm reduction and created new opportunities for
implementation of harm reduction philosophy and approaches,
including programs that incorporate the provision of alcohol as
medicine as part of the substance use treatment continuum.
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